# Evaluation of PET Scan Timing Relative to AV-45 Injection Time

> **NCT01565356** · NA · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 41 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT01565356
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01565356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01565356, "Evaluation of PET Scan Timing Relative to AV-45 Injection Time". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01565356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*